Product Information
FEXOFENADINE-PSE ER 180-240 TB is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.8669 per EA under NDC 55111055735. Its NADAC has been published 87 times since May 22, 2024.
Strength
180; 240 mg/1; mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
55111055735
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
1/22/2025
Active Ingredients
FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA079043On Market Since
8/24/2011
Pharmacological Classes
Price Statistics
The NADAC for FEXOFENADINE-PSE ER 180-240 TB has been published 87 times since May 22, 2024, and over the history we have for it it has declined 12.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8669 per EA |
|---|---|
| All-time high | $1.0292 (Jul 10, 2024) |
| All-time low | $0.8669 (Nov 20, 2024) |
| 52-week high | $0.8669 |
| 52-week low | $0.8669 |
| Median price | $0.8669 |
| Average price | $0.8936 |
| Largest weekly change | -8.7% (Aug 21, 2024) |
| Weeks tracked | 87 |
| Tracking since | May 22, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Fexofenadine HCl and Pseudoephedrine HCI market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of FEXOFENADINE-PSE ER 180-240 TB?
The current National Average Drug Acquisition Cost (NADAC) for FEXOFENADINE-PSE ER 180-240 TB, manufactured by Dr. Reddy's Laboratories Inc., is $0.8669 per EA (NDC 55111055735), effective Jan 14, 2026.
How has the price of FEXOFENADINE-PSE ER 180-240 TB changed over time?
Over the history we have for it, the NADAC for FEXOFENADINE-PSE ER 180-240 TB has declined 12.1%. It has been tracked across 87 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for FEXOFENADINE-PSE ER 180-240 TB?
Since May 22, 2024, the NADAC for FEXOFENADINE-PSE ER 180-240 TB has ranged from a low of $0.8669 (Nov 20, 2024) to a high of $1.0292 (Jul 10, 2024), with a median of $0.8669 per EA.
Are there cheaper alternatives to FEXOFENADINE-PSE ER 180-240 TB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of FEXOFENADINE-PSE ER 180-240 TB, so no direct lower-cost alternative is listed.
Who manufactures FEXOFENADINE-PSE ER 180-240 TB?
FEXOFENADINE-PSE ER 180-240 TB (NDC 55111055735) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification